Kane Slutzkin

Stock Analyst at Deutsche Bank

(2.60)
# 2,861
Out of 4,574 analysts
32
Total ratings
45.5%
Success rate
4.4%
Average return

Stocks Rated by Kane Slutzkin

Oxford Nanopore Technologies plc
Jul 21, 2026
Maintained: Buy
Price Target: 195p
Current: 108p
Upside: +80.89%
Hikma Pharmaceuticals PLC
Jun 22, 2026
Reiterated: Buy
Price Target: 2,400p1,950p
Current: 1,582p
Upside: +23.26%
IP Group Plc
Mar 18, 2026
Maintained: Buy
Price Target: 103p110p
Current: 66p
Upside: +65.66%
NIOX Group Plc
Jan 21, 2026
Maintained: Buy
Price Target: 86p
Current: 64p
Upside: +35.22%
Oxford Biomedica plc
Jan 6, 2026
Upgraded: Buy
Price Target: 735p
Current: 571p
Upside: +28.72%
CVS Group plc
Oct 21, 2025
Reiterated: Buy
Price Target: 1,500p1,700p
Current: 1,196p
Upside: +42.14%
Medicover AB (publ)
Sep 26, 2025
Maintained: Hold
Price Target: kr 265.00
Current: kr 218.50
Upside: +21.28%
Spire Healthcare Group plc
Sep 22, 2025
Maintained: Buy
Price Target: 300p
Current: 224p
Upside: +33.93%
Smith & Nephew plc
Aug 7, 2025
Maintained: Hold
Price Target: 1,300p1,400p
Current: 1,140p
Upside: +22.81%
Uniphar plc
Jul 30, 2025
Reiterated: Hold
Price Target: 375p
Current: 383p
Upside: -2.09%
Reiterated: Buy
Price Target: 275p
Current: 280p
Upside: n/a
Downgraded: Hold
Price Target: 440p400p
Current: 450p
Upside: n/a
Maintained: Buy
Price Target: 315p
Current: 216p
Upside: n/a